[1]
Khudhair , M.S. et al. 2023. Real-World Observational Study in Patients on Teneligliptin Therapy for the Management of Type 2 Diabetes Mellitus. World Journal of Pharmacy and Biotechnology. 10, 1 (Jan. 2023), 01–07. DOI:https://doi.org/10.30904/j.wjpbt.2023.4470.